(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...

But there are indications that large swaths of corporate America are already beginning to sour on Trump, as concerns grow ...

Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...

Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

Griffin, who voted for Trump but did not donate to his campaign, believes the president's "bombastic rhetoric" on tariffs is ...

Ken Griffin, founder of investment firm Citadel, warned Tuesday that President Donald Trump's tariff policies pose a serious ...

Kraft Heinz ( KHC) is close to a 52-week low after it reported a 4.6% decline in sales during Q4. Organic sales fell -3.1% ...

Federal Reserve Chair Jerome Powell heads back to Capitol Hill for a second day of testimony.

The hope was that 2025 would be the year that the volatility in the commercial real estate sector would start to end. That still might be the case — but it won't come without some headwinds, as ...

We recently published a list of 12 Best Chocolate Stocks to Buy According to Hedge Funds. In this article, we are going to ...